A carregar...
Real World Experience of Daratumumab: Evaluating Lymphopenia and Adverse Events in Multiple Myeloma Patients
Multiple myeloma (MM) is an incurable disease with a limited life expectancy of five years from diagnosis. Uncontrolled disease or infections are the main causes of mortality. Daratumumab, a monoclonal antibody against CD38, is approved to treat patients with MM. Its target, CD38, is expressed not o...
Na minha lista:
| Publicado no: | Front Oncol |
|---|---|
| Main Authors: | , , , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Frontiers Media S.A.
2021
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7917249/ https://ncbi.nlm.nih.gov/pubmed/33659205 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2020.575168 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|